TRIM71
E3 ubiquitin-protein ligase TRIM71
Also known as: LIN-41, LIN41, LIN41_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2Q1W2
- Gene
- TRIM71
- Ensembl
- ENSG00000206557
- Chromosome
- 3
- Canonical length
- 868 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Actin filaments,Focal adhesion sites
OverviewNCBI Gene
The protein encoded by this gene is an E3 ubiquitin-protein ligase that binds with miRNAs and maintains the growth and upkeep of embryonic stem cells. This gene also is involved in the G1-S phase transition of the cell cycle. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
868 residues, UniProt reviewed canonical sequence.
>Q2Q1W2|TRIM71
1 MASFPETDFQ ICLLCKEMCG SPAPLSSNSS ASSSSSQTST SSGGGGGGPG AAARRLHVLP
61 CLHAFCRPCL EAHRLPAAGG GAAGEPLKLR CPVCDQKVVL AEAAGMDALP SSAFLLSNLL
121 DAVVATADEP PPKNGRAGAP AGAGGHSNHR HHAHHAHPRA SASAPPLPQA PQPPAPSRSA
181 PGGPAASPSA LLLRRPHGCS SCDEGNAASS RCLDCQEHLC DNCVRAHQRV RLTKDHYIER
241 GPPGPGAAAA AQQLGLGPPF PGPPFSILSV FPERLGFCQH HDDEVLHLYC DTCSVPICRE
301 CTMGRHGGHS FIYLQEALQD SRALTIQLLA DAQQGRQAIQ LSIEQAQTVA EQVEMKAKVV
361 QSEVKAVTAR HKKALEEREC ELLWKVEKIR QVKAKSLYLQ VEKLRQNLNK LESTISAVQQ
421 VLEEGRALDI LLARDRMLAQ VQELKTVRSL LQPQEDDRVM FTPPDQALYL AIKSFGFVSS
481 GAFAPLTKAT GDGLKRALQG KVASFTVIGY DHDGEPRLSG GDLMSAVVLG PDGNLFGAEV
541 SDQQNGTYVV SYRPQLEGEH LVSVTLCNQH IENSPFKVVV KSGRSYVGIG LPGLSFGSEG
601 DSDGKLCRPW GVSVDKEGYI IVADRSNNRI QVFKPCGAFH HKFGTLGSRP GQFDRPAGVA
661 CDASRRIVVA DKDNHRIQIF TFEGQFLLKF GEKGTKNGQF NYPWDVAVNS EGKILVSDTR
721 NHRIQLFGPD GVFLNKYGFE GALWKHFDSP RGVAFNHEGH LVVTDFNNHR LLVIHPDCQS
781 ARFLGSEGTG NGQFLRPQGV AVDQEGRIIV ADSRNHRVQM FESNGSFLCK FGAQGSGFGQ
841 MDRPSGIAIT PDGMIVVVDF GNNRILVFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM71 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 4.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 4.5 nTPM
- kidney: 0.8 nTPM
- basal ganglia: 0.7 nTPM
- lung: 0.7 nTPM
- amygdala: 0.3 nTPM
- hypothalamus: 0.3 nTPM
Single-cell type
- undifferentiated spermatogonia: 44 nCPM
- proximal tubule cells: 43 nCPM
- retinal amacrine cells: 33 nCPM
- extravillous trophoblasts: 25 nCPM
- distal convoluted tubule cells: 23 nCPM
- thymocytes: 20 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 2.9 nTPM
- basal ganglia: 2.9 nTPM
- hippocampal formation: 2.8 nTPM
- cerebral cortex: 2.6 nTPM
- hypothalamus: 2.6 nTPM
- pons: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRIM71.
Disease | AllUniProt
Conditions TRIM71 is implicated in, by any mechanism.
- Hydrocephalus, congenital, 4 (HYC4) MIM:618667
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 175 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hydrocephalus, congenital communicating, 1
- Congenital hydrocephalus
- Non-obstructive azoospermia
- TRIM71-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.28
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 3'-UTR-mediated mRNA destabilization
- fibroblast growth factor receptor signaling pathway
- G1/S transition of mitotic cell cycle
- miRNA processing
- miRNA-mediated gene silencing by inhibition of translation
- negative regulation of translation
- neural tube closure
- neural tube development
- positive regulation of miRNA-mediated gene silencing
- post-transcriptional regulation of gene expression
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein autoubiquitination
- protein polyubiquitination
- regulation of neural precursor cell proliferation
- stem cell proliferation
Molecular functions
- miRNA binding
- translation repressor activity
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B-box-type zinc finger
- NHL repeat
- Filamin/ABP280 repeat
- Zinc finger, RING-type
- Six-bladed beta-propeller, TolB-like
- Zinc finger, RING/FYVE/PHD-type
- Immunoglobulin-like fold
- Immunoglobulin E-set
- Filamin/ABP280 repeat-like
- Zinc finger, RING-type, conserved site
- Zinc finger, C3HC4 RING-type
- Tripartite Motif and NHL Repeat Containing E3 Ligases
- Zinc finger, C3HC4 type (RING finger)
- Filamin/ABP280 repeat
- B-box zinc finger
- NHL repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIM71 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM71 as an antibody target. Whether an autoantibody or antibody against TRIM71 could matter depends on whether native TRIM71 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM71 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM71 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...